Published in Vaccine Weekly, April 18th, 2001
C.J. Harrison and colleagues at Creighton University, Nebraska, evaluated imiquimod alone or in combination with HSV vaccine in animals inoculated genitally with HSV. Their findings were published in Vaccine.
Animals infected with HSV-2 were allowed to recover, then randomized to receive placebo, imiquimod alone for days 16 through 37, or the imiquimod regimen in addition to HSV-2 glycoprotein vaccine on days 16 and 37.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.